Drug Type Small molecule drug |
Synonyms- |
Action agonists |
Mechanism 20S proteasome agonists(20S proteasome agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 02 Jul 2024 | |
| Cardiovascular Diseases | Discovery | - | 02 Jul 2024 | |
| Diabetes Mellitus | Discovery | - | 02 Jul 2024 | |
| Diabetes Mellitus | Discovery | - | 02 Jul 2024 | |
| Neurodegenerative Diseases | Discovery | - | 02 Jul 2024 | |
| Neurodegenerative Diseases | Discovery | - | 02 Jul 2024 |





